What you can expect from this situation:
A form, Determination of Campus to Review Research Form, was developed to determine which IRB office will review and approve your research proposal. You do not have to submit this form if your study involves the following, please proceed with submitting your study to HSC IRB for review/approval:
- Participants with a medically diagnosed condition
- Studies with FDA controlled substances or supplements
- Studies involving blood flow restriction
What steps will you take during this process:
- To request this form, please email us at irb@ou.edu.
- Submit this form and an IRB Protocol Description form to irb@ou.edu for Chair/Vice Chair review. The form and Protocol will be reviewed to determine which campus would be appropriate for submission based on the cumulative estimated risk across the four categories and information provided in your Protocol. You will receive a determination response by email.
- If it is determined that your study is to be reviewed by the Norman campus IRB, please submit your study using iRIS.
- If your study is determined to go to HSC IRB, the investigator will be notified by email. A courtesy email will be sent by the OU Norman IRB office to both the investigator and HSC IRB office notifying them of the determination.
Do you need to complete CITI Training?
Yes. However, each IRB campus has different training requirements so it is best to wait until you receive a response before you complete the training.
What else do you need to submit with your application?
If it is determined that the Norman campus IRB will review your study, proceed with the Generic Research Application Process described in "Question #6: Are you collecting data from living individuals?". If it is determined that HSC IRB will review your study, they have not implemented iRIS to date so you must submit your application using the current HSC IRB forms located on their website: http://www.ouhsc.edu/irb/.